MARS 2026 attracted 15,693 visitors over three days, featuring demonstrations and hands-on experiences of integrated digital healthcare at the AI Smart Hospital pavilion. The exhibit recreated actual hospital wards, diagnostic labs, and rehabilitation centers, showcasing a seamless workflow from patient monitoring to AI-driven diagnostics and therapy. The model combines Dongtan City Hospital's smart ward operational expertise with technologies from 13 partner companies.
Daewoong Pharmaceutical and Dongtan City Hospital have unveiled an 'AI Smart Hospital' model that encompasses everything from patient monitoring to artificial intelligence (AI) diagnostics, testing, and rehabilitation. By integrating the smart ward operational experience of Dongtan City Hospital with the technologies of 13 partners in the Daewoong Alliance, the companies demonstrated how these services can be interconnected in a clinical setting.
Daewoong Pharmaceutical (CEOs Lee Chang-jae and Park Sung-soo) announced on the 11th that it operated a joint exhibition pavilion with Dongtan City Hospital and its partners at 'AI EXPO MARS 2026,' held at COEX in Samseong-dong, Seoul, from the 3rd to the 5th. The event, hosted by Hwaseong City and organized by the Hwaseong Industry Promotion Agency, drew a total of 15,693 visitors over the three-day period.
[Photo: Visitors gather at the smart diagnostic and testing lab to experience various medical technologies, including digital pulmonary function tests and AI-based sarcopenia screening. / Courtesy of Daewoong Pharmaceutical]
From Patient Monitoring to Robotic Rehabilitation: Visitors Experience the AI Medical Frontier
The two organizations set up an approximately 180-square-meter pavilion divided into an AI smart ward, a diagnostic and testing lab, and a rehabilitation center. Each space demonstrated medical technologies used for patient monitoring, diagnostics, and rehabilitation in a realistic hospital environment.
The centerpiece of the ward demonstration was Seers' AI smart bedside monitoring system, 'thynC.' A demonstrator wearing a hospital gown and wearable devices showcased how vital signs are monitored in real-time via 'thynC.' Large monitors behind the bed displayed key biometric data, including heart rate, ECG, blood pressure, blood glucose, body temperature, and oxygen saturation.
AI was also utilized to relay patient requests to medical staff. When a patient scans a QR code attached to the bed with a smartphone and speaks their request, the AI processes the voice information and transmits it to the nursing station.
In the diagnostic and testing lab, six zones showcased portable X-rays, digital pulmonary function tests, and AI-based sarcopenia diagnostic assistance. Technologies that analyze fundus images to screen for disease risks or analyze endoscopic images in real-time were also demonstrated, allowing visitors to view medical devices alongside AI analysis screens.
At the rehabilitation center, a demonstrator wearing Hurotics' wearable robot, 'H-medi,' performed gait training on a treadmill. Visitors were able to experience the technology firsthand and view AI analysis results of their movement posture. The exhibit also introduced 'Cogthera,' a digital therapeutic device for mild cognitive impairment developed by Emocog.
The company noted that visitors showed significant interest in real-time patient monitoring, wearable robotic rehabilitation, and AI-based sarcopenia and fundus screenings, with queues forming for some of the interactive programs.
[Photo: A nurse demonstrates the smart ward operation process, checking the vital signs of a patient wearing a wearable device at the Daewoong Pharmaceutical and Dongtan City Hospital joint pavilion. / Courtesy of Daewoong Pharmaceutical]
Expanding AI Smart Hospital Implementation Based on Real-World Operational Experience
Dongtan City Hospital, the foundation of this exhibition, has been operating with 'thynC' installed in all its beds in collaboration with Daewoong Pharmaceutical and Seers. Based on the experience gained from this implementation, the partners showcased how AI diagnostics and digital rehabilitation technologies can be integrated with ward operations to provide comprehensive medical services.
Hwaseong Mayor Jung Myung-keun, along with officials from local public health centers, hospitals, and healthcare companies, visited the pavilion to observe the technology demonstrations and learn about the smart ward operation model. Daewoong Pharmaceutical plans to strengthen cooperation with medical institutions and Daewoong Alliance partners to expand the application of digital healthcare technologies in clinical settings.
Kim Mi-young, Administrative Director of Dongtan City Hospital, stated, "At MARS 2026, we were able to vividly demonstrate how AI medical technology is implemented and utilized in actual clinical settings. We will continue to combine cutting-edge medical technology with the expertise of our medical staff to innovate patient-centered services and develop an AI smart hospital model that leads the digital transformation of local medical institutions."
Lee Chang-jae, CEO of Daewoong Pharmaceutical, remarked, "The AI smart hospital is no longer a blueprint for the future; it is a change already being realized in medical practice. Daewoong Pharmaceutical will combine the industry's highest level of clinically validated digital healthcare technologies to present an integrated AI smart hospital model—rather than individual solutions—to address the challenges faced in clinical settings."
